1460884253-7f0bc81f-5993-4074-b531-993dccec281f

1. A method for treating Multiple Myeloma, FGFR3+ myeloma, especially relapsed or refractory multiple myeloma (414) expressing FGFR3, comprising administering a dual C-KITFGFR3 inhibitor to a human in need of such treatment.
2. The method according to claim 1 or 2 wherein said inhibitor is selected from the group consisting of 2-aminoarylthiazoles and 2-aminoaryloxazoles.
3. The method according to claim 2, wherein said inhibitor is selected from compounds of formula I:
wherein substituents Z, A, B, B\u2032, Q and R1-R6 in Formula I are defined as follows:
Z is oxygen or sulfur.
A and B\u2032 is one of the following:
i) (R7)N(CH2)n where n is 0 or 1
ii) O(CH2)n where n is 0 or 1
iii) S(CH2)n where n is 0 or 1
iv) (CH2)n where n is 0, 1 or 2
v) C(O)(CH2)n where n is 0 or 1

or when A and B\u2032 each are a nitrogen, they may be taken together to form a bivalent radical of formula:
\u2014(CH2)s-X1-(CH2)t-\u2003\u2003(a)
where s and t each independently is 1 or 2 and X1 being O, S, NR10, NC(\u2550O)R10 or (CH2)n where n is 0 or 1, and wherein each hydrogen in said formula (a) may be substituted with halo or C1-4alkyl.
B is one of the following:
i) (R7)N
ii) Oxygen
iii) S(O)n where n is 0, 1 or 2
iv) CH(R7)(R8)
v) C=\u03b4, where \u03b4 is oxygen, sulfur, NH or N\u2014CN
vi) C(R7)=C(R8)
vii) N\u2550C(R7)
R7 and R8 each independently are hydrogen, C1-4alkyl, C2-6alkenyl, C2-6alkynyl, C3-7cycloalkyl, C1-4haloalkyl, C1-4alkoxy, C1-4hydroxyalkyl, C1-4alkylamino.
R1 and R2 is selected from:
i) hydrogen, halogen (selected from F, Cl, Br or I), or
ii) an alkyl1 group defined as a linear, branched or cycloalkyl group containing from 1 to 10 carbon atoms and optionally substituted with one or more hetereoatoms such as halogen (selected from F, Cl, Br or I), oxygen, and nitrogen (the latter optionally in the form of a pendant basic nitrogen functionality); as well as trifluoromethyl, carboxyl, cyano, nitro, formyl; as well as CO\u2014R, COO\u2014R, CONH\u2014R, SO2-R, and SO2NH\u2014R wherein R is a linear or branched alkyl group containing 1 to 10 carbon atoms and optionally substituted with at least one heteroatom, notably a halogen (selected from F, Cl, Br or I), oxygen, and nitrogen, the latter optionally in the form of a pendant basic nitrogen functionality; as well as a cycloalkyl or aryl1 or heteroaryl1 group optionally substituted by a pendant basic nitrogen functionality, or
iii) an aryl1 group defined as phenyl or a substituted variant thereof bearing any combination, at any one ring position, of one or more substituents such as
Halogen (selected from I, F, Cl or Br);
an alkyl1 group;
a cycloalkyl, aryl or heteroaryl group optionally substituted by a pendant basic nitrogen functionality;
trifluoromethyl, O-alkyl1, carboxyl, cyano, nitro, formyl, hydroxy, NH-alkyl1, N(alkyl1)(alkyl1), and amino, the latter nitrogen substituents optionally in the form of a basic nitrogen functionality;
NHCO\u2014R or NHCOO\u2014R or NHCONH\u2014R or NHSO2-R or NHSO2NH\u2014R or CO\u2014R or COO\u2014R or CONH\u2014R or SO2-R or SO2NH\u2014R or C(NOH)NH2, C(N)NH2 wherein R corresponds to hydrogen, alkyl1, aryl or heteroaryl, or

iv) a heteroaryl1 group defined as a pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, thienyl, thiazolyl, imidazolyl, pyrazolyl, pyrrolyl, furanyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, indolyl, benzimidazole, benzoxazole, benzothiazole quinolinyl group, which may additionally bear any combination, at any one ring position, of one or more substituents such as
halogen (selected from F, Cl, Br or I);
an alkyl1 group;
a cycloalkyl, aryl or heteroaryl group optionally substituted by a pendant basic nitrogen functionality,
trifluoromethyl, O-alkyl1, carboxyl, cyano, nitro, formyl, hydroxy, NH-alkyl1, N(alkyl1)(alkyl1), and amino, the latter nitrogen substituents optionally in the form of a basic nitrogen functionality;
NHCO\u2014R or NHCOO\u2014R or NHCONH\u2014R or NHSO2-R or NHSO2NH\u2014R or CO\u2014R or COO\u2014R or CONH\u2014R or SO2\u2014R or SO2NH\u2014R wherein R corresponds to hydrogern, alkyl1, or

v) an O-aryl1, or NH-aryl1, or O-heteroaryl1 or NH-heteroaryl1 group
vi) trifluoromethyl, O-alkyl1, carboxyl, cyano, nitro, formyl, hydroxy, NH-alkyl1, N(alkyl1)(alkyl1), and amino, the latter nitrogen substituents optionally in the form of a basic nitrogen functionality, or
vi) NHCO\u2014R or NHCOO\u2014R or NHCONH\u2014R or NHSO2-R or NHSO2NH\u2014R or CO\u2014R or COO\u2014R or CONH\u2014R or SO2\u2014R or SO2NH\u2014R wherein R corresponds to hydrogen, alkyl1, aryl1 or heteroaryl1.
R3, R4, R5 and R6 each independently are selected from hydrogen, halogen (selected from F, Cl, Br or I), a linear or branched alkyl group containing from 1 to 10 carbon atoms and optionally substituted with one or more hetereoatoms such as halogen (selected from F, Cl, Br or I), oxygen, and nitrogen, the latter optionally in the form of a pendant basic nitrogen functionality; as well as trifluoromethyl, C1-6alkyloxy, amino, C1-6alkylamino, di(C1-6alkyl)amino, carboxyl, cyano, nitro, formyl, hydroxy, and CO\u2014R, COO\u2014R, CONH\u2014R, SO2\u2014R, and SO2NH\u2014R wherein R corresponds to hydrogen, alkyl1, aryl or heteroaryl.

and wherein Q is selected from:
i) Alkyl1
ii) Aryl1
iii) Heteroaryl1

as defined above.
4. The method according to claim 3, wherein said inhibitor is selected from compounds of formula II:
Z is oxygen or sulfur.
Aryl1, Heteroaryl1, R1, R2 and R3 have the meaning described above.
5. The method according to claim 3, wherein said inhibitor is selected from compounds of formula III:
Z is oxygen or sulfur.
Aryl1, Heteroaryl1, R1, R2 and R3 have the meaning described above.
6. The method according to claim 3, wherein said inhibitor is selected from compounds of formula IV:
Wherein W is C\u2550O or SO2.
Z is oxygen or sulfur.
L is selected from Alkyl1, Aryl1 or Heteroaryl1 as defined above.
R1, R2, R3, R4, R5 and R6 have the meaning described above.
R9 is selected from hydrogen, a linear or branched alkyl group containing from 1 to 10 carbon atoms and optionally substituted with one or more hetereoatoms such as halogen (selected from F, Cl, Br or I), oxygen, and nitrogen, the latter optionally in the form of a pendant basic nitrogen functionality; C1-6alkyloxy, amino, hydroxyl.
7. A method according to one of claims 1 to 6, wherein said inhibitor is:
N-{3-5-(4-Cyano-phenyl)-oxazol-2-ylamino-4-methyl-phenyl}-3-trifluoromethyl-benzamide
4-(4-Methyl-piperazin-1-ylmethyl)-N-4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl-benzamide
N-(3-Chloro-phenyl)-4-methyl-3-(5-pyridin-4-yl-oxazol-2-ylamino)-benzamide
4-Methyl-N-4-(4-methyl-piperazin-1-ylmethyl)-phenyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-benzamide
N-4-Methyl-3-(5-pyridin-4-yl-oxazol-2-ylamino)-phenyl-C-phenyl-methanesulfonamide
N-4-Methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl-C-phenyl-methane sulfonamide
8. The use of a compound as defined in one of claims 1 to 7 to manufacture a medicament for treating Multiple Myeloma such as FGFR3+ myeloma.
9. The use of a compound as defined in one of claims 1 to 7 to manufacture a medicament for treating relapsed or refractory multiple myeloma (414) expressing FGFR3.
10. A pharmaceutical composition comprising a compound as defined in one of claims 1 to 7 and dexamethasone suitable for a simultaneous or separate administration over time.
11. A method for treating Multiple Myeloma (MM), FGFR3+ myeloma, especially relapsed or refractory multiple myeloma (414) expressing FGFR3, comprising administering a suitable amount of a compound as defined in one of claims 1 to 7 and dexamethasone to a human in need of such treatment.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. An electric generator for harvesting the energies of atomic oscillators comprising:
(a) an antennawaveguide that is geometrically optimized having a conducting surface;
(b) a primary coil wound with an insulated conductor over a secondary coil, the coil being connected to an AC or AC-DC driver; and
(c) a secondary coil of smaller diameter than the primary coil having a greater length and a greater number of turns than the primary coil and having a first lead and a second lead, the secondary coil being positioned coaxially within the first coil and acting as a resonant step-up transformer winding inductively coupled with the primary and an external capacitor connected in parallel with the secondary coil to provide a specific resonant frequency; or
(d) a secondary coil of smaller diameter than the primary coil having a greater length and a greater number of turns than the primary coil and having a first lead and a second lead, the secondary coil being positioned coaxially within the first coil and acting as a resonant step-up transformer winding inductively coupled with the primary and connected with the antennawaveguide serving as a quasi-capacitive series element to provide a specific resonant frequency;
wherein the conducting surface of the antennawaveguide is configured such that the secondary coil is attached near the point at which the electric field contacts the antennawaveguide;
wherein the generator absorbs impulses from Earth’s electric oscillations; and wherein the attracted energy manifests as high voltage sinusoidal waveforms in the secondary coil, representing harvested atmospheric and telluric electrical energy and measurable on the leads of the secondary coil.
2. The electric generator of claim 1, wherein a suitable voltage is greater than 500 VRMS.
3. The electric generator of claim 1, wherein the antennawaveguide is designed based on ratios of pi and phi.
4. The electric generator of claim 1, wherein the antennawaveguide is of pyramidal shape.
5. The electric generator of claim 1, wherein the antennawaveguide is placed on an insulated base.
6. The electric generator of claim 1, wherein the antennawaveguide is at a high voltage during the operation of the generator.
7. The electric generator of claim 6, wherein the antennawaveguide voltage is greater than 500 VRMS.
8. The electric generator of claim 1, wherein the antennawaveguide is connected to an oscillator.
9. The electric generator of claim 8, wherein the oscillator comprises a resonant step-up transformer.
10. The electric generator of claim 4, wherein the secondary coil of the transformer is connected near the apex of the antennawaveguide.
11. The electric generator of claim 1 wherein the second lead of the secondary coil is connected to earth ground.
12. The electric generator of claim 1 wherein the primary coil is wound with a conductor over the secondary coil, the primary coil being connected electrically to a driver operating in the LF or ELF bands.
13. The electric generator of claim 1, wherein the primary coil is inductively coupled to the secondary coil.
14. An electric generator for harvesting the electric emissions of atomic oscillations of claim 1 comprising an oscillator.
15. The electric generator of claim 14, wherein said oscillator operates in the LF or ELF bands.
16. The electric generator of claim 14 wherein the generator comprises:
(a) a primary coil wound with a conductor over a secondary coil, the coil being connected electrically to a driver operating in the LF or ELF bands; and
(b) a secondary coil of smaller diameter than the primary coil having a greater length and a greater number of turns than the primary coil, the secondary coil being positioned coaxially within the first coil and acting as a resonant step-up transformer winding inductively coupled with the primary; wherein said resonant step-up transformer’s output voltage exceeds 500VRMS;
wherein the electric generator attracts impulses from Earth’s electric oscillations; and
wherein the attracted energy manifests as high voltage sinusoidal waveforms representing harvested electric energy of atomic oscillations in the secondary coil and measurable on leads of the secondary coil.
17. The electric generator of claim 4, wherein the height of the pyramidal electric generator is from about 0.50 m to about 1000 m.
18. The electric generator of claim 4, wherein the base surface area of the pyramid is from about 0.25 m2 to about 1,000,000 m2.
19. The electric generator of claim 1, wherein the generator is positioned in a generally north-south direction.